CVS Group (CVSG) Completes Purchase of 107,761 Shares at Up to 1,322p Under May 2026 Buyback Plan

CVS Group plc (CVSG), a veterinary services provider operating in the UK and Australia, has announced the acquisition of 107,761 ordinary shares between 1 and 4 September 2026 as part of its ongoing share buyback programme initiated on 26 May 2026. The shares were bought through Berenberg at prices ranging from 1,273p to 1,322p, with a volume weighted average price of 1,299.03p. CVS plans to cancel all repurchased shares, reducing the total shares outstanding to 67,862,629. Since the programme's inception, the company has repurchased a total of 2,300,470 ordinary shares at a weighted average price of 1,251.3 pence per share. Key Points CVS Group plc (CVSG) is listed on the London Stock Exchange Main Market 107,761 ordinary shares bought between 1 and 4 September 2026 via Berenberg, all to be cancelled Purchase price ranged from 1,273p to 1,322p; volume weighted average price was 1,299.03p per share Investors should monitor cumulative buyback progress and future updates to the programme announced on 26 May 2026 CVS Group Acquires 107,761 Shares in September at Prices Between 1,273p and 1,322p Between 1 and 4 September 2026, CVS Group acquired 107,761 ordinary shares of 0.2 pence each via Joh. Berenberg, Gossler & Co. KG, London Branch. The lowest price paid was 1,273.00p and the highest was 1,322.00p, with a volume weighted average price of 1,299.03p per share. These purchases align with the terms of the share buyback programme announced on 26 May 2026. A detailed breakdown of the trades executed by Berenberg has been published through the London Stock Exchange's regulatory news service. All Repurchased Shares to Be Cancelled, Reducing Shares in Issue to 67,862,629 CVS Group confirmed it will cancel all ordinary shares acquired in this tranche instead of holding them in treasury. After settlement and cancellation, the total number of ordinary shares in issue will be 67,862,629, with no shares held in treasury. This total also represents the number of voting rights in CVS Group and is the figure shareholders should use to determine notification requirements under the Financial Conduct Authority's Disclosure and Transparency Rules. 2,300,470 Shares Repurchased Since May 2026 Programme Launch at Average Price of 1,251.3p Since the share buyback programme began on 26 May 2026, CVS Group has repurchased a total of 2,300,470 ordinary shares at a weighted average price of 1,251.3 pence per share. The programme complies with Article 5(1)(b) of Regulation (EU) No 596/2014, as retained in UK law under the European Union (Withdrawal) Act 2018. Notably, the average price paid in the latest tranche, 1,299.03p, exceeds the programme-to-date weighted average, reflecting the share price range available during this period. CVS Group Operates Over 475 Veterinary Practices Across UK and Australia CVS Group is a leading veterinary services provider with more than 475 practices throughout the United Kingdom and Australia, including specialist referral hospitals and dedicated out-of-hours facilities. The group employs around 9,000 staff, including 2,500 veterinary surgeons and 3,300 nurses. Beyond its core veterinary practices, CVS runs a diagnostics laboratory serving internal and external clients, as well as Animed Direct, an online retail business. This extensive scale and multi-channel veterinary services model support CVS Group's position as a Main Market-listed leader in the expanding animal healthcare sector.